NCT05383300View on ClinicalTrials.gov

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

March 1, 2020

Study Completion Date

December 1, 2021

Conditions
Antisocial Personality Disorder
Interventions
DRUG

Oxytocin nasal spray

Intranasal spray containing 40 IU of oxytocin

OTHER

Placebo spray

Application of inert placebo, identical in odor, color, and droplet size except for absence of oxytocin

Trial Locations (1)

SE58AF

Insititue of Psychiarty, Psychology and Neuroscience, London

All Listed Sponsors
collaborator

Father Flanagan's Boys' Home

OTHER

lead

King's College London

OTHER

NCT05383300 - Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy | Biotech Hunter | Biotech Hunter